# Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN

> **NCT02718521** · NA · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Cardio-Renal Syndrome

## Interventions

- **PROCEDURE:** Hydration Combined With Intravenous Infusion of Isosorbide Dinitrate
- **DRUG:** Visipaque
- **DRUG:** 0.9% sodium chloride fluid administration
- **DRUG:** isosorbide dinitrate

## Key facts

- **NCT ID:** NCT02718521
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-04
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718521, "Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02718521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*